Press Release | June 15, 2023
Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS
Read More
News | June 15, 2023
ImCheck selected as laureate of the new French Tech 2030 program
Read More
Press Release | June 15, 2023
Walgreens and Freenome Establish Partnership to Increase Diversity in Research for the Early Detection of Cancer
Read More
Press Release | June 5, 2023
Dragonfly Therapeutics Announces the Presentation of Phase 1 DF1001 TriNKET® Dose Escalation Results
Read More
